...BRCA2 are associated with a hereditary risk of breast cancer, and dysregulation of their expression has been observed in...
...BRCA2 breast carcinoma and to determine the factors that may predict their risk of CBC.,The study sample consisted of al...
...BRCA2 mutations. Ovarian cancer patients were tested for BRCA1 mutations. We estimated standardized incidence ratios (SI...
...BRCA2.,The present study showed a continuous increase in the number of patients with breast cancer; the proportion of yo...
...BRCA2), appear to cooperate in a pathway leading to the recognition and repair of damaged DNA. Molecular interactions am...
...BRCA2.,Real-time polymerase chain reaction amplification with SYBR Green I detection was performed on DNA from cell line...
...BRCA2 mutations (median age 43 years, range 27 to 65 years) were scheduled for six-monthly NA, DL and venesection. DL wa...
...BRCA2 mutations are at substantial risk for breast and ovarian cancer. This review describes recent developments in the ...
...BRCA2 mutations. Jewish Israeli women with breast cancer (n=385) were genotyped for the three predominant Jewish mutatio...
...BRCA2 patient; discrete focal atypia of tubal and ovarian epithelium in a patient with a negative BRCA1/BRCA2 mutation a...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
